Immune Landscape of Epstein –Barr Virus–Associated Gastric Cancer: Analysis From a Western Academic Institution

Epstein –Barr virus–associated gastric cancer (EBVaGC) may be a meaningful biomarker for potential benefit from immunotherapy. Further investigation is needed to characterize the immune landscape of EBVaGC. We assessed our institutional frequency of surgically treated EBVaGC and analyzed the immunologic biomarker profile and tumor-infiltrating lymphocyte (TIL) phenotypes of a series of EBVaGC compared to non-EBVaGC cases.

Source: Journal of Surgical Research - February 17, 2024 Category: Surgery Authors: Elliott J. Yee, Danielle Gilbert, Jeffrey Kaplan, Linda van Dyk, Sunnie S. Kim, Leslie Berg, Eric Clambey, Sachin Wani, Martin D. McCarter, Camille L. Stewart Tags: Surgical Oncology Source Type: research